Asmaa Badr
Impact in
-
- Gout, Hyperuricemia, Uric Acid
-
- Vibrio bacteria research studies
Papers in
-
- Inflammasome and immune disorders 4
- S100 Proteins and Annexins 1
-
- Immune Response and Inflammation 2
- Co-authors
- Kathrin Krause (10 shared papers)Amal O. Amer (11 shared papers)Mikhail A. Gavrilin (9 shared papers)Kyle Caution (6 shared papers)Kylene P. Daily (9 shared papers)Shady Estfanous (8 shared papers)Xiaoli Zhang (7 shared papers)Arwa Abu Khweek (7 shared papers)
- Journals
- Journal of Cystic Fibrosis (3 papers)Scientific Reports (2 papers)Tetrahedron (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)Cellular Immunology (1 paper)
- Partner nations
- United StatesPalestinian TerritoryEgypt
In The Last Decade
Asmaa Badr
14 papers receiving 260 citations
Peers
Comparison fields: 5 of 63
- Nephrology 34
- Endocrinology 18
- Immunology 67
- Pulmonary and Respiratory Medicine 66
- Molecular Biology 146
Countries citing papers authored by Asmaa Badr
This map shows the geographic impact of Asmaa Badr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa Badr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa Badr more than expected).
Fields of papers citing papers by Asmaa Badr
This network shows the impact of papers produced by Asmaa Badr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa Badr. The network helps show where Asmaa Badr may publish in the future.
Co-authors
The 25 scholars most cited alongside Asmaa Badr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 61 | |
| 2 | 2018 | 45 | |
| 3 | 2019 | 29 | |
| 4 | 2021 | 23 | |
| 5 | 2019 | 23 | |
| 6 | 2017 | 22 | |
| 7 | 2022 | 20 | |
| 8 | 1972 | 19 | |
| 9 | 2020 | 9 | |
| 10 | 2021 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2024 | 1 |
About Asmaa Badr
Asmaa Badr is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Physiology and Rheumatology, having authored 14 papers that have together received 264 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (4 papers), Inflammasome and immune disorders (4 papers), Vibrio bacteria research studies (2 papers), Immune Response and Inflammation (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Alzheimer's disease research and treatments (1 paper), S100 Proteins and Annexins (1 paper) and Structural and Chemical Analysis of Organic and Inorganic Compounds (1 paper). The work is most often cited by research in Nephrology (34 citations), Endocrinology (18 citations), Immunology (67 citations), Pulmonary and Respiratory Medicine (66 citations) and Molecular Biology (146 citations). Asmaa Badr has collaborated with scholars based in United States, Palestinian Territory and Egypt. Frequent co-authors include Kathrin Krause, Amal O. Amer, Mikhail A. Gavrilin, Kyle Caution, Kylene P. Daily, Shady Estfanous, Xiaoli Zhang, Arwa Abu Khweek, Mostafa Eltobgy and Frank Robledo‐Avila. Their work appears in journals such as Journal of Cystic Fibrosis, Scientific Reports, Tetrahedron, Frontiers in Cellular and Infection Microbiology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.